Limited to estrogen receptor-positive breast cancer (ER+) the compound addresses many common concerns with existing treatment.

obviously it’s new and recent research, but holy heck

  • SocialMediaRefugee@lemmy.worldEnglish
    3·
    5 days ago

    They used human tumors in mice so it was being tested against human tumors. The main issue is that the mice were immunocompromised so it would stand to be tested in humans with functional immune systems.